Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
98.297,43
3,81%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Exagen Inc (XGN) Exagen Inc (XGN) Notizie

Exagen Inc

XGN
5,03
0,08 (1,62%)
Ultimo aggiornamento: 20:08:07
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/12/202423:00EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/12/202415:00GLOBEExagen Inc. Achieves Key Milestone with 1,000,000th Patient..
27/11/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202401:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202422:30GLOBEExagen Inc. Completes Validation and Regulatory Submission..
13/11/202422:05GLOBEExagen Inc. to Participate in Fourth Quarter Investor..
12/11/202414:00GLOBEExagen Inc. Reports Third Quarter 2024 Results
29/10/202421:05GLOBEExagen to Announce Third Quarter 2024 Results on November..
21/10/202422:05GLOBEExagen Announces Acceptance of Five Abstracts at 2024..
08/10/202422:39EDGAR2Form 144 - Report of proposed sale of securities
05/9/202400:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/9/202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202422:05GLOBEExagen Inc. to Participate in the 2024 Cantor Global..
09/8/202423:08EDGAR2Form 144 - Report of proposed sale of securities
05/8/202415:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202414:00EDGAR2Form 8-K - Current report
05/8/202414:00GLOBEExagen Inc. Reports Strong Second Quarter 2024..
02/8/202423:20EDGAR2Form 8-K/A - Current report: [Amend]
02/8/202415:00GLOBEExagen Inc. to Participate in the Canaccord Genuity 44th..
02/8/202414:15EDGAR2Form 8-K - Current report
01/8/202415:00GLOBEExagen Appoints Jeffrey G. Black as New Chief Financial..
22/7/202415:00GLOBEExagen to Announce Second Quarter 2024 Results on August 5,..
12/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:08EDGAR2Form 8-K - Current report
17/5/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:25APSHealthcare Shares Soar Following Major Price Target Increase
13/5/202415:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/5/202415:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202414:00EDGAR2Form 8-K - Current report
13/5/202414:00GLOBEExagen Inc. Reports Strong First Quarter 2024..
06/5/202422:05GLOBEExagen Announces Campaign for Lupus Awareness Month
30/4/202422:05GLOBEExagen to Announce First Quarter 2024 Results on May 13,..
26/4/202414:30GLOBEExagen Inc. Announces Changes to the Board of Directors
18/3/202413:00GLOBEExagen Inc. Reports Strong Fourth Quarter and Full-Year 2023..
18/3/202412:12IHMARKETNEWSAnticipation Builds on Wall Street for Federal Reserve’s..
08/3/202415:00GLOBEExagen Inc. to Participate in the KeyBanc Capital..
07/3/202422:05GLOBEExagen to Announce Fourth Quarter 2023 and Full-Year..
06/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202413:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202421:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202422:05GLOBEExagen Inc. to Participate in the 2024 BTIG MedTech, Digital..
22/1/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: 5,10 Min: 4,68 Max: 5,30
Chiusura: 4,95

La tua Cronologia

NASDAQ
XGN
Exagen
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network